By Chris Wack Ocugen shares were up 9% at 45 cents after the company said the National Institute of Allergy and Infectious Diseases, a part of the National…
Markets – MarketWatch
Ocugen Shares Rise 9% After OCU500 Inclusion in NIAID Trial Markets – MarketWatch
